Wix reported Q3 2026 earnings per share of $1.42, surpassing the $1.40 estimate, and revenue of $570.2 million, exceeding the $566.3 million forecast. Bookings grew 11% to $573 million, with revenue up 13%, driven mainly by Base44's strong performance nearing $250 million in annual recurring revenue. Wix's non-GAAP gross margin remained stable at 69%, while Base44's margin improved significantly to 58%. The company also launched Studio Two, an AI-powered platform for designers and agencies, signaling continued innovation and growth potential.
Wix's typical hold time on Pluang is 65 days, with its price at USD 66.74 as of Nov 10, 2026 18:12 WIB. For readers following Technology-sector US stocks, here is Pluang's market snapshot: out of 150 stocks, 51 rose and 89 fell today. Notable movers include GRAB at USD 3.23 with a 6.10% decline and ASX at USD 36.43 with a 6.02% gain, while Wix itself dropped 4.32%.
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
The global paracetamol market is projected to grow from $12.05 billion in 2026 to $15.39 billion by 2032, with a CAGR of 4.12%. Growth is driven by increasing demand for pain and fever management, expanded access to over-the-counter medicines, and in...
ESET Research uncovered a sophisticated cyberespionage tool named Cereal, used by the Russia-aligned Turla group to spy on emails within Microsoft Exchange servers of governmental organizations in Kazakhstan and Romania. The tool stealthily collects ...
Registration is now open for Brand Licensing Expo 2027, scheduled for May 25-27 at Mandalay Bay, Las Vegas. The event, rebranded from Licensing Expo, features over 265 confirmed exhibitors including major brands like Amazon MGM Studios, Coca-Cola, an...
Trogenix, a clinical-stage precision oncology company, has appointed John Young as Chair and Josh Murray as Non-Executive Director to support its global strategy, commercial growth, and US expansion. John Young brings over 35 years of pharmaceutical ...
